Stocktoria
BOSTON SCIENTIFIC CORP BSX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1992-05-19
BOSTON SCIENTIFIC CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $20.1B | $16.7B | $14.2B | $12.7B | $11.9B |
| Gross profit | $13.9B | $11.5B | $9.9B | $8.7B | $8.2B |
| SG&A expense | $6.9B | $6.0B | $5.2B | $4.5B | $4.4B |
| Operating income | $3.6B | $2.6B | $2.3B | $1.6B | $1.2B |
| Interest expense | $349.0M | $305.0M | $265.0M | $470.0M | $341.0M |
| Income tax | $493.0M | $436.0M | $393.0M | $443.0M | $36.0M |
| Operating cash flow | $4.5B | $3.4B | $2.5B | $1.5B | $1.9B |
| Free cash flow | $3.7B | $2.6B | $1.8B | $938.0M | $1.3B |
| Cash & equivalents | $2.0B | $414.0M | $865.0M | $928.0M | $1.9B |
| Inventory | $2.9B | $2.8B | $2.5B | $1.9B | $1.6B |
| Total assets | $43.7B | $39.4B | $35.1B | $32.5B | $32.2B |
| Shareholders' equity | $24.5B | $22.0B | $19.5B | $17.6B | $16.6B |
| EPS (diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 |
Source: SEC EDGAR filings · CIK 0000885725 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.